Tetrahydrocoptisine is primarily used in pharmacological research due to its notable biological activities. It exhibits anti-inflammatory and analgesic effects, making it a candidate for developing pain-relief and anti-arthritic agents. The compound also shows potential in treating neurological disorders because of its ability to cross the blood-brain barrier and modulate neurotransmitter systems. Additionally, it has demonstrated antimicrobial properties against certain pathogens, suggesting possible use in infection control. Its role as a metabolic intermediate in biosynthetic pathways further supports its importance in studying alkaloid biosynthesis and drug development.